Researchers reviewed 31 previous clinical trials to see if different blood purification devices could help people with severe septic shock, a life-threatening condition. The review included data from 2,678 patients and compared 15 different treatment approaches to standard care. The main question was whether these devices could lower the death rate.
The analysis found that only two specific devices—the TORAYMYXIN (PMX) filter and the HA 330—were linked to lower death rates when compared to standard treatment. Another method, called convection, was linked to a higher death rate. The study did not report how much lower or higher these rates were, or how many patients were affected.
This type of study, called a network meta-analysis, compares many treatments indirectly. Because it didn't provide specific numbers or confidence intervals for its findings, the results should be viewed as a signal for further research, not as definitive proof. For patients and families, this means scientists have identified two devices that may be worth studying more closely in future, direct comparisons to see if they truly help save lives in septic shock.